A detailed history of M&G PLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, M&G PLC holds 149,210 shares of GILD stock, worth $15.5 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
149,210
Previous 172,568 13.54%
Holding current value
$15.5 Million
Previous $14.5 Billion 5.3%
% of portfolio
0.08%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

SELL
$83.95 - $97.9 $1.96 Million - $2.29 Million
-23,358 Reduced 13.54%
149,210 $13.7 Billion
Q3 2024

Oct 31, 2024

BUY
$66.59 - $83.99 $1.19 Million - $1.5 Million
17,851 Added 11.54%
172,568 $14.5 Billion
Q2 2024

Jul 16, 2024

BUY
$63.15 - $72.88 $3.64 Million - $4.21 Million
57,709 Added 59.49%
154,717 $10.7 Billion
Q1 2024

May 10, 2024

BUY
$71.58 - $87.29 $6.94 Million - $8.47 Million
97,008 New
97,008 $7.08 Billion

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $130B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track M&G PLC Portfolio

Follow M&G PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&G PLC, based on Form 13F filings with the SEC.

News

Stay updated on M&G PLC with notifications on news.